Citi Venture Capital International is selling its entire stake in CEE-focused pharmaceutical company, Sanitas, to Valeant Pharmaceuticals International. The buyer will acquire about 27,122,593 ordinary registered shares in Sanitas at €10-12 per unit. After the completion of the transaction, Valeant will launch a mandatory takeover offer to acquire the remaining shares in Sanitas from minority shareholders. Jefferies International is the sole financial advisor to Sanitas on the deal.

Click here for the release from Sanitas Group.